Bpifrance
VC Fund
Maisons-alfort, France
Bpifrance is a VC fund in Maisons-alfort focused on Software and Health Care. Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
- Total investments:
- 1710
- Last investment:
- Lead investor:
- 27%
- Fund size:
- $27M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Bpifrance invests in
Stages Bpifrance invests in
Countries Bpifrance invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 33 contacts → | |||
Round size
- Seed
- $752k–$6.1M
- Series A
- $2.6M–$34M
- Venture - Series Unknown
- $1.1M–$31M
Investment Focus
Industry
- Software 262 (15%)
- Health Care 159 (9%)
- Biotechnology 157 (9%)
- Information Technology 156 (9%)
- Manufacturing 131 (8%)
Stage
- Seed 430 (25%)
- Venture - Series Unknown 254 (15%)
- Series A 206 (12%)
- Series B 126 (7%)
- Debt Financing 115 (7%)
Country
- France 1222 (71%)
- United States 41 (2%)
- Switzerland 7 (0%)
- Belgium 6 (0%)
- United Kingdom 5 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Adrien Neel
Investment Director
|
Investment Director | Total investments: 2 | Find email | |
Arnaud Legardeur
Investment Director
|
Investment Director | Total investments: 1 | Find email | |
Cédric Clement
Senior Investment Director | Bpifrance Deeptech Venture
|
Senior Investment Director | Bpifrance Deeptech Venture | Total investments: 1 | Find email | |
Charlotte Corbaz
Investment Drector - Large Venture
|
Investment Drector - Large Venture | Total investments: 3 | Find email | |
Clarisse Blandin
Investment director
|
Investment director | Total investments: 2 | Find email | |
| See all 33 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Healthcare professionals are now overwhelmed by the volume of patients and images. They need new tools. As safeguards of our Healthcare system, they need to be empowered and to participate in the AI production process. This is our mission through our co-creation projects. | $16M / Venture - Series Unknown / Sep 22, 2026 | ||
| Hackuity is a comprehensive cybersecurity solution that orchestrates and automates the vulnerability management process.Hackuity’s platform aggregates and normalizes all your security assessment practices, whether automated or handmade, and enriches them so security practitioners can, at last, create risk-driven remediation plans and align theirpriorities with their current and future exposure to threats.Fully customizable, the platform fits the client technical context and security requirements either in a full-Saas mode, On-premise or Hybrid installation mode.Hackuity proposes the right offer regarding the company's experience in vulnerability management and field of activity : - Risk-based vulnerability management - Continuous Monitoring - Augmented pentest - Hackuity for MSSPThe company was founded in 2018 and is based in Lyon, France. | $18.5M / Series B / Sep 16, 2026 | ||
| FIMAC specializes in the implementation of application management solutions for EBP, SAGE, CEGID and develops adapted IT solutions. | Private Equity / Sep 15, 2026 | ||
| Kaiko is a digital assets market data provider, offering global data connectivity to more than 100 centralized and decentralized cryptocurrency exchanges. Our guiding mission is to bridge the gap between traditional and crypto finance by providing actionable financial data and services. Our four business units — Market Data, Quantitative Analytics,Indices and Research — empower use cases across the investment lifecycle. | $57M / Series B / Sep 14, 2026 | ||
| Ed AI provides an AI platform for automated grading, feedback, and personalized learning materials in education. | $5.8M / Seed / Sep 11, 2026 | ||
| Arlequin AI provides an AI-native platform for critical decision-making and high-stakes data analysis. Its technology uses unsupervised and topological AI to identify patterns, relationships, trends, and causal links across large datasets without generating text or relying on context windows. The platform supports applications including financialanalysis, forensics, due diligence, logistics, supply chain analysis, cybersecurity, and intelligence. | $32.6M / Series A / Sep 10, 2026 | ||
| Olenbee develops fintech solutions that connect employee benefits directly to everyday card spending. The company offers a mobile application and employer platform that link meal vouchers, gift vouchers and other planned benefits to employees’ usual bank cards and accounts. Its title-restaurant product Olenfood allows food-related expenses to beidentified from card transactions and reimbursed in line with regulation. The Olengift service applies the same principle to gift vouchers without dedicated cards or closed merchant networks. Olenbee also works on additional benefit lines such as culture, sustainable mobility, sport, holidays and home office support. Its infrastructure is designed to handle eligibility rules and integrate with HR and payroll processes for employers, while providing dedicated spaces for merchants and employees. | $7.5M / Seed / Sep 08, 2026 | ||
| Nūmi mission to redefine health through groundbreaking research making the unparalleled benefits of breast milk accessible to all. | $4.3M / Grant / Sep 02, 2026 | ||
| Digicuto develops robotic and software solutions for aesthetic dentistry that support dentists in performing complex restorative and cosmetic treatments. The company creates the Lupin robotic platform, which integrates a robotic arm with modular application software for planning and executing dental procedures. Digicuto focuses on digitizingclinical expertise so that standardized workflows can be applied to veneer preparation and other smile restoration treatments. Its technology combines digital planning, CAD design and robotic guidance to prepare teeth and place restorations in a controlled manner. Digicuto serves dental practitioners seeking to improve consistency, efficiency and predictability in aesthetic dental care. | Debt Financing / Aug 28, 2026 | ||
| newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming. | Grant / Aug 26, 2026 | ||
| See all 1710 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Bpifrance invest in?
Bpifrance invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Venture - Series Unknown stage. Most of the 1,710 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Bpifrance's check size?
Bpifrance typically joins rounds of $752k–$6.1M at Seed, $2.6M–$34M at Series A and $1.1M–$31M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Bpifrance participates in.
How do I contact Bpifrance?
Public channels for Bpifrance include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Bpifrance?
The team at Bpifrance includes Adrien Neel (Investment Director), Arnaud Legardeur (Investment Director) and Cédric Clement (Senior Investment Director | Bpifrance Deeptech Venture), among 33 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
